Cargando…

Risk factors for mortality among COVID-19 patients

AIMS: COVID-19 is a current global pandemic. However, comprehensive global data analyses for its mortality risk factors are lacking. The current investigation aimed to assess the predictors of death among COVID-19 patients from worldwide open access data. METHODS: A total of 828 confirmed cases of C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albitar, Orwa, Ballouze, Rama, Ooi, Jer Ping, Sheikh Ghadzi, Siti Maisharah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332436/ https://www.ncbi.nlm.nih.gov/pubmed/32623035 http://dx.doi.org/10.1016/j.diabres.2020.108293

Ejemplares similares

A Repeated Time-to-Positive Symptoms Improvement among Malaysian Patients with Schizophrenia Spectrum Disorders Treated with Clozapine
por: Albitar, Orwa, et al.
Publicado: (2021)

Population Pharmacokinetics of Clozapine: A Systematic Review
por: Albitar, Orwa, et al.
Publicado: (2020)

Predictive model of recurrent ischemic stroke: model development from real-world data
por: Elhefnawy, Marwa Elsaeed, et al.
Publicado: (2023)

A Retrospective Study on Tuberculous Lymphadenitis: A Finding from Multicenter Referral Hospitals
por: Mohiuddin, Syed Ghouse, et al.
Publicado: (2022)

Pharmacometrics Approaches and its Applications in Diabetes: An Overview
por: Aziz, Sohail, et al.
Publicado: (2021)

Risk assessment of atherosclerotic cardiovascular diseases before statin therapy initiation: Knowledge, attitude, and practice of physicians in Yemen
por: Al-Ashwal, Fahmi Y., et al.
Publicado: (2022)

A Standardized Dataset of a Spontaneous Adverse Event Reporting System
por: Khaleel, Mohammad Ali, et al.
Publicado: (2022)

Can Newer Anti-Diabetic Therapies Delay the Development of Diabetic Nephropathy?
por: Aziz, Sohail, et al.
Publicado: (2021)

Physicians and pharmacists’ clinical knowledge of statin therapy and monitoring parameters, and the barriers to guideline implementation in clinical practice
por: Al-Ashwal, Fahmi Y., et al.
Publicado: (2023)

Metformin Use in Gestational Diabetes: Awareness, Attitude, and Practice among Healthcare Professionals in Malaysia
por: Daud, Nur Aizati Athirah, et al.
Publicado: (2021)

Healthcare workers’ knowledge, preparedness, counselling practices, and perceived barriers to confront COVID-19: A cross-sectional study from a war-torn country, Yemen
por: Al-Ashwal, Fahmi Y., et al.
Publicado: (2020)

Use of Traditional Chinese Medicine in Malaysia: A Knowledge and Practice Study among General Population toward Complementary and Alternative Medicine in Relation to Health and Quality of Life in Malaysia
por: Mohiuddin, Syed Ghouse, et al.
Publicado: (2021)

In vitro cytotoxic and antimicrobial activities of Erythrina suberosa (Roxb) bark
por: Ahmed, Zubair, et al.
Publicado: (2020)

Phytochemical screening and enzymatic and antioxidant activities of Erythrina suberosa (Roxb) bark
por: Ahmed, Zubair, et al.
Publicado: (2020)

Gender Differences and Risk Factors of Recurrent Stroke in Type 2 Diabetic Malaysian Population with History of Stroke: The Observation from Malaysian National Neurology Registry
por: Aziz, Sohail, et al.
Publicado: (2019)

Population-based Study Comparing Predictors of Ischemic Stroke Recurrence After Index Ischemic Stroke in Non-elderly Adults with or without Diabetes
por: Elhefnawy, Marwa Elsaeed, et al.
Publicado: (2021)

Impact of adherence to key performance indicators on mortality among patients managed for ischemic stroke
por: Mohammed, Mustapha, et al.
Publicado: (2020)

Factors Associated with Mortality Among Hospitalized Adults with COVID-19 Pneumonia at a Private Tertiary Hospital in Tanzania: A Retrospective Cohort Study
por: Kassam, Nadeem, et al.
Publicado: (2021)

Evaluation of diagnostic parameters in detecting prediabetes in a cohort of Syrian healthcare providers and staff: correlations with risk factors
por: Albitar, Lina
Publicado: (2022)

Implications for Drug Characterization in Glucose Tolerance Tests Without Insulin: Simulation Study of Power and Predictions Using Model‐Based Analysis
por: Sheikh Ghadzi, SM, et al.
Publicado: (2017)

Clinical characteristics and risk factors for mortality in patients with COVID-19: A retrospective nationwide study in Malaysia
por: Ismail, Siti NA, et al.
Publicado: (2022)

Identification of risk factors for mortality in COVID-19 patients
por: Kim, Eun Young
Publicado: (2020)

Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19
por: Wang, Liqin, et al.
Publicado: (2020)

Clinical Risk Factors for Mortality Among Critically Ill Mexican Patients With COVID-19
por: Hernández-Cárdenas, Carmen M., et al.
Publicado: (2021)

Risk factors for infection and mortality among hemodialysis patients during COVID-19 pandemic
por: Can, Özgür, et al.
Publicado: (2021)

IMPACT OF DEMENTIA AS AN EARLY MORTALITY RISK FACTOR AMONG DECEASED PATIENTS WITH COVID-19
por: RUIZ, CARLOS A PEREZ, et al.
Publicado: (2022)

Risk Factors for COVID‐19 Mortality Among People Living with HIV
por: Varshney, Karan, et al.
Publicado: (2021)

Clinical characteristics and risk factors for mortality in cancer patients with COVID-19
por: Liang, Junnan, et al.
Publicado: (2021)

Short- and Long-Term Mortality and Mortality Risk Factors among Nursing Home Patients after COVID-19 Infection
por: Booij, Johannes A., et al.
Publicado: (2022)

Risk Factors Associated with Mortality Among Patients with Novel Coronavirus Disease (COVID-19) in Africa
por: Mohammed, Mustapha, et al.
Publicado: (2020)

Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis
por: Noor, Farha Musharrat, et al.
Publicado: (2020)

Epidemiological characteristics and mortality risk factors among COVID-19 patients in Ardabil, Northwest of Iran
por: Adham, Davoud, et al.
Publicado: (2021)

Acid–base imbalance as a risk factor for mortality among COVID-19 hospitalized patients
por: Al-Azzam, Nosayba, et al.
Publicado: (2023)

Risk factors for in-hospital mortality in patients with cancer and COVID-19
por: Guo, Kaibo, et al.
Publicado: (2020)

Risk factors for in-hospital mortality in patients with cancer and COVID-19
por: Zhang, Guosen, et al.
Publicado: (2020)

Risk Factors for Mortality in Patients with COVID-19: The Kuwait Experience
por: Al Saleh, Mohammad, et al.
Publicado: (2022)

Risk factors for COVID-19 mortality in hospitalized patients in Bolivia
por: Limachi-Choque, Jhonny, et al.
Publicado: (2023)

Risk factors for COVID-19 severity and mortality among inpatients in Southern Iran
por: REZAEI, FATEMEH, et al.
Publicado: (2022)

Risk Factors Associated With Six-Month Mortality in Hospitalized COVID-19 Patients: A Single-Institution Study
por: Kahlon, Navkirat, et al.
Publicado: (2022)

Synonymous Polymorphisms in HOXB13 as a Protective Factor for Prostate Cancer
por: Albitar, Ferras, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tv4bi6b7jopcvr3bmu6483u842